Rigetti Computing Skyrockets To Record High As Investor Confidence Soars
'Moana 2' Continues Record-setting Run as 'Wicked' Comes in Second
Microsoft's Plan to Win the Console War: Make Everything an Xbox
AstraZeneca Announced Fixed-duration Calquence Plus Venetoclax Demonstrated Superior PFS Vs. Standard Of Care In Previously Untreated CLL, With 77% Of Patients Progression Free At Three Years In AMPLIFY Phase III Trial At ASH Meeting
Apple, Sony Have Discussed Collaborating on Controllers for Vision Pro: Report
Tesla's Challenges, Rivian's Triumph, And Lucid's Ambitions: This Week In EVs
GenAI Being Adopted at Double the Pace of PCs or Internet
Intel, UnitedHealth And Rocket Lab Are Among Top 11 Large Cap Losers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Meta's Llama 3.3 70B Outshines Rivals, Nvidia's Liquid-Cooling Breakthrough, XAI Raises $6B: This Week In AI
Super Micro Computer, Lululemon And Roku Are Among Top 11 Large Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?
Earnings Week Ahead: ORCL, GME, ADBE, COST, AVGO, M and More
NXP Semiconductors, Broadcom Among Deutsche Bank's Chip Stocks for 2025
Apple's In-House Modems, Foldable IPhones, And Tim Cook On Cupertino's Future: This Week In Appleverse
Can Stocks Pull Off a Third Consecutive Year of Big Gains?
Fed Officials Flag Inflation Concerns Ahead of Meeting on Rates
- Regeneron Announced Novel Combination Of Pozelimab And Cemdisiran Achieved Greater Control Of Intravascular Hemolysis In Patients With Paroxysmal Nocturnal Hemoglobinuria Vs Ravulizumab
Executive Reshuffles: INTC, ZS, ETSY and SEDG
Amgen Announced Blincyto Added To Chemotherapy Significantly Improves Survival In Newly Diagnosed Pediatric Patients With B-cell Precursor Acute Lymphoblastic Leukemia At ASH; Said Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival...
Musk Fuels Speculation On US Bitcoin Reserve As Crypto Surges
OpenAI's ChatGPT Makes Headway In Search, Threatening Google's Reign